
|Videos|January 19, 2023
Optimizing Patient Outcomes with JAK Inhibitors
Author(s)Brett King, MD, PhD, Alexandra K. Golant, MD
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
2
New Review Confirms How Nonmedicated Skin Care Vehicles Drive Clinical Improvement
3
Dermatology Times Spot Test: July 19, 2026
4
Social Media Mythbusters: The Summer Skin Care "Shutdown"
5
















